Your browser doesn't support javascript.
Mortality and survival of COVID-19.
Sousa, G J B; Garces, T S; Cestari, V R F; Florêncio, R S; Moreira, T M M; Pereira, M L D.
  • Sousa GJB; Postgraduation Program in Clinical Care in Nursing and Health, Ceará State University, Fortaleza, Ceará, Brazil.
  • Garces TS; Postgraduation Program in Clinical Care in Nursing and Health, Ceará State University, Fortaleza, Ceará, Brazil.
  • Cestari VRF; Postgraduation Program in Clinical Care in Nursing and Health, Ceará State University, Fortaleza, Ceará, Brazil.
  • Florêncio RS; Postgraduation Program in Clinical Care in Nursing and Health, Ceará State University, Fortaleza, Ceará, Brazil.
  • Moreira TMM; Postgraduation Program in Clinical Care in Nursing and Health, Ceará State University, Fortaleza, Ceará, Brazil.
  • Pereira MLD; Postgraduation Program in Clinical Care in Nursing and Health, Ceará State University, Fortaleza, Ceará, Brazil.
Epidemiol Infect ; 148: e123, 2020 06 25.
Article in English | MEDLINE | ID: covidwho-615328
ABSTRACT
This study aims to identify the risk factors associated with mortality and survival of COVID-19 cases in a state of the Brazilian Northeast. It is a historical cohort with a secondary database of 2070 people that presented flu-like symptoms, sought health assistance in the state and tested positive to COVID-19 until 14 April 2020, only moderate and severe cases were hospitalised. The main outcome was death as a binary variable (yes/no). It also investigated the main factors related to mortality and survival of the disease. Time since the beginning of symptoms until death/end of the survey (14 April 2020) was the time variable of this study. Mortality was analysed by robust Poisson regression, and survival by Kaplan-Meier and Cox regression. From the 2070 people that tested positive to COVID-19, 131 (6.3%) died and 1939 (93.7%) survived, the overall survival probability was 87.7% from the 24th day of infection. Mortality was enhanced by the variables elderly (HR 3.6; 95% CI 2.3-5.8; P < 0.001), neurological diseases (HR 3.9; 95% CI 1.9-7.8; P < 0.001), pneumopathies (HR 2.6; 95% CI 1.4-4.7; P < 0.001) and cardiovascular diseases (HR 8.9; 95% CI 5.4-14.5; P < 0.001). In conclusion, mortality by COVID-19 in Ceará is similar to countries with a large number of cases of the disease, although deaths occur later. Elderly people and comorbidities presented a greater risk of death.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Coronavirus Infections Type of study: Etiology study / Incidence study / Observational study / Prognostic study / Risk factors Topics: Long Covid Limits: Adult / Aged / Female / Humans / Male / Middle aged Country/Region as subject: South America / Brazil Language: English Journal: Epidemiol Infect Journal subject: Communicable Diseases / Epidemiology Year: 2020 Document Type: Article Affiliation country: S0950268820001405

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Coronavirus Infections Type of study: Etiology study / Incidence study / Observational study / Prognostic study / Risk factors Topics: Long Covid Limits: Adult / Aged / Female / Humans / Male / Middle aged Country/Region as subject: South America / Brazil Language: English Journal: Epidemiol Infect Journal subject: Communicable Diseases / Epidemiology Year: 2020 Document Type: Article Affiliation country: S0950268820001405